Metformin for patients with diabetes and concomitant renal restrictions--is there an evidence base?

No abstract is available for this paper.

• Publication year

  2013

• Venue

  QJM : monthly journal of the Association of Physicians

• Publication date

  2013-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/qjmed/hct016PMID 23349404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• New‐Onset Diabetes After Kidney Transplantation—Changes and Challenges

  2012cited by this paper
• Diabetes, metformin and lactic acidosis

  2011cited by this paper
• Should Metformin Be Our Antiglycemic Agent of Choice Post‐transplantation?

  2011cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function

  2010cited by this paper
• Metformin, Sulfonylureas, or Other Antidiabetes Drugs and the Risk of Lactic Acidosis or Hypoglycemia

  2008cited by this paper
• Diabetes Management Issues for Patients With Chronic Kidney Disease

  2007cited by this paper
• New-onset diabetes after transplantation.

  2004cited by this paper
• New-onset diabetes after transplantation: 2003 International consensus guidelines. Proceedings of an international expert panel meeting. Barcelona, Spain, 19 February 2003.

  2003cited by this paper
• When are medication side effects due to the nocebo phenomenon

  2002cited by this paper
• Evaluation of prescribing practices: risk of lactic acidosis with metformin therapy.

  2002cited by this paper
• Frequency of inappropriate metformin prescriptions.

  2002cited by this paper
• Metformin-associated lactic acidosis: case reports and literature review.

  2002cited by this paper
• Contraindications to metformin therapy in patients with Type 2 diabetes—a population‐based study of adherence to prescribing guidelines

  2001cited by this paper
• Lactic acidosis in metformin-treated patients. Prognostic value of arterial lactate levels and plasma metformin concentrations.

  1999cited by this paper
• Lactic Acidosis in Metformin-Treated Patients

  1999cited by this paper
• Kidney Function and Age Are Both Predictors of Pharmacokinetics of Metformin

  1995cited by this paper
• Hemodialysis in the treatment of lactic acidosis in diabetics treated by metformin: a study of metformin elimination.

  1989cited by this paper
• Metformin kinetics in healthy subjects and in patients with diabetes mellitus.

  1981cited by this paper

• Protective effect of seabuckthorn seed protein on renal function in diabetic mice

  2025cites this paper
• Interventions Against Posttransplantation Diabetes: A Scientific Rationale for Treatment Hierarchy Based on Literature Review.

  2022cites this paper
• Safety and Efficacy of Long-Term Administration of Dipeptidyl peptidase IV Inhibitors in Patients With New Onset Diabetes After Kidney Transplant.

  2021cites this paper
• Renal safety profile of di-peptidyl-peptidase inhibitors: a review of available literature

  2017cites this paper
• Metformin and its use in chronic kidney disease, cardiovascular disease and cancer

  2015cites this paper
• Post‐transplantation diabetes mellitus: evaluation of treatment strategies

  2015cites this paper
• Efficacy and Safety of Vildagliptin in New‐Onset Diabetes After Kidney Transplantation—A Randomized, Double‐Blind, Placebo‐Controlled Trial

  2014cites this paper
• Glycaemic control and glucose-lowering therapy in diabetic patients with kidney disease

  2014cites this paper
• Patient-centred care in diabetology Strategy for improving diabetes care in Nigeria Treatment for diabetic patients with kidney disease Choosing an insulin regime in developing countries Peripheral neuropathy in diabetic amputees

  2014cites this paper
• Evaluation and Management of Transplant-Associated Hyperglycemia

  2014cites this paper
• Clinical practice considerations and review of the literature for the Use of DPP-4 inhibitors in patients with type 2 diabetes and chronic kidney disease.

  2013cites this paper
• Pharmacological modulation of insulin resistance : benefits and harms

  2013cites this paper
• Sulfonylureas and meglitinides: historical and contemporary issues.

  2013cites this paper